Artal Group S.A. - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 31 filers reported holding ATYR PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2018$406,000
-10.8%
500,0000.0%0.01%
+10.0%
Q2 2018$455,000
-65.7%
500,0000.0%0.01%
-41.2%
Q1 2018$1,325,000
-24.3%
500,0000.0%0.02%
-34.6%
Q4 2017$1,750,000
+38.6%
500,000
+100.0%
0.03%
+18.2%
Q3 2017$1,263,000250,0000.02%
Other shareholders
ATYR PHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$18,755,00012.78%
EcoR1 Capital, LLC 840,462$8,623,0003.92%
Rock Springs Capital Management LP 388,996$3,991,0000.32%
SPHERA FUNDS MANAGEMENT LTD. 209,027$2,145,0000.27%
Baker Brothers Advisors 2,335,125$23,958,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$4,735,0000.18%
TIVERTON ASSET MANAGEMENT LLC 472,236$4,845,0000.11%
RS INVESTMENT MANAGEMENT CO LLC 1,082,249$11,104,0000.10%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$4,262,0000.07%
Magnetar Financial LLC 354,659$3,639,0000.05%
View complete list of ATYR PHARMA INC shareholders